Pharma and Healthcare Social Media Comprehensive Study by Application (Hospitals, Clinics, Pharmaceutical, Others), Social Media (Facebook, LinkedIn, Youtube, Instagram, Others) Players and Region - Global Market Outlook to 2028

Pharma and Healthcare Social Media Market by XX Submarkets | Forecast Years 2023-2028  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Pharma and healthcare social media can be used for connecting the customers, physicians, patients, and other professionals online. It is basically used for building its brand presence and increase its reach by conveying proper, accurate, and balanced information. Social media like Facebook, LinkedIn, Youtube, Instagram, and other such platforms are used. The pharma and healthcare companies mainly use branches of marketing for their promotion and customer engagement.This growth is primarily driven by Growing Demand for Online Presence of Companies for Brand Awareness and Global Reach .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Internet Software & Services sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as AstraZeneca plc (United Kingdom), Sermo (United States), Doximity (United States), Abbott Healthcare (United States), Merck KGaA (Germany), unmetric (United States), Pfizer Inc. (United States), AbbVie Inc. (United States) and GlaxoSmithKline plc. (United Kingdom), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.



Regulatory Insights:
"The Internet and various social media platforms have increasingly enabled drug and device manufacturers to more actively engage with consumers and healthcare providers. FDA held a Part 15 public hearing to gather comments and questions from our stakeholders (e.g., industry, health care providers, consumers, patient groups, Internet vendors, advertising agencies, and other interested parties) on how the FDA can best provide guidance on the promotion of FDA-regulated medical products (including prescription drugs for humans and animals, prescription biologics, and medical devices) using the Internet and social media tools."

Influencing Trend:
The popularity of Various Social Media Channels Among the Popular Healthcare and Pharma Companies

Market Growth Drivers:
Growing Demand for Online Presence of Companies for Brand Awareness and Global Reach and Digital Transformation in a Way of Socializing and Communication

Challenges:
Number of Local Pharma and Healthcare Companies Present in Social Media Market

Restraints:
Stringent Regulatory Compliances Associated with the Pharma and Healthcare Social Media

Opportunities:
Growing Young Population in Social Media Platform will Boost the Pharma and Healthcare Social Media Market and Increasing Number of Digital Marketing Companies Across the World Serving Different Sectors

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Pharma and Healthcare Social Media Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Pharma and Healthcare Social Media Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Pharma and Healthcare Social Media players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Pharma and Healthcare Social Media Study Sheds Light on
— The Pharma and Healthcare Social Media Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Pharma and Healthcare Social Media industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Pharma and Healthcare Social Media industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Application
  • Hospitals
  • Clinics
  • Pharmaceutical
  • Others
By Social Media
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Online Presence of Companies for Brand Awareness and Global Reach
      • 3.2.2. Digital Transformation in a Way of Socializing and Communication
    • 3.3. Market Challenges
      • 3.3.1. Number of Local Pharma and Healthcare Companies Present in Social Media Market
    • 3.4. Market Trends
      • 3.4.1. The popularity of Various Social Media Channels Among the Popular Healthcare and Pharma Companies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharma and Healthcare Social Media, by Application, Social Media and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Pharma and Healthcare Social Media (Value)
      • 5.2.1. Global Pharma and Healthcare Social Media by: Application (Value)
        • 5.2.1.1. Hospitals
        • 5.2.1.2. Clinics
        • 5.2.1.3. Pharmaceutical
        • 5.2.1.4. Others
      • 5.2.2. Global Pharma and Healthcare Social Media by: Social Media (Value)
        • 5.2.2.1. Facebook
        • 5.2.2.2. LinkedIn
        • 5.2.2.3. Youtube
        • 5.2.2.4. Instagram
        • 5.2.2.5. Others
      • 5.2.3. Global Pharma and Healthcare Social Media Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Pharma and Healthcare Social Media: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AstraZeneca plc (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sermo (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Doximity (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott Healthcare (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merck KGaA (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Unmetric (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Pfizer Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. AbbVie Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. GlaxoSmithKline plc. (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Pharma and Healthcare Social Media Sale, by Application, Social Media and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Pharma and Healthcare Social Media (Value)
      • 7.2.1. Global Pharma and Healthcare Social Media by: Application (Value)
        • 7.2.1.1. Hospitals
        • 7.2.1.2. Clinics
        • 7.2.1.3. Pharmaceutical
        • 7.2.1.4. Others
      • 7.2.2. Global Pharma and Healthcare Social Media by: Social Media (Value)
        • 7.2.2.1. Facebook
        • 7.2.2.2. LinkedIn
        • 7.2.2.3. Youtube
        • 7.2.2.4. Instagram
        • 7.2.2.5. Others
      • 7.2.3. Global Pharma and Healthcare Social Media Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharma and Healthcare Social Media: by Application(USD Million)
  • Table 2. Pharma and Healthcare Social Media Hospitals , by Region USD Million (2017-2022)
  • Table 3. Pharma and Healthcare Social Media Clinics , by Region USD Million (2017-2022)
  • Table 4. Pharma and Healthcare Social Media Pharmaceutical , by Region USD Million (2017-2022)
  • Table 5. Pharma and Healthcare Social Media Others , by Region USD Million (2017-2022)
  • Table 6. Pharma and Healthcare Social Media: by Social Media(USD Million)
  • Table 7. Pharma and Healthcare Social Media Facebook , by Region USD Million (2017-2022)
  • Table 8. Pharma and Healthcare Social Media LinkedIn , by Region USD Million (2017-2022)
  • Table 9. Pharma and Healthcare Social Media Youtube , by Region USD Million (2017-2022)
  • Table 10. Pharma and Healthcare Social Media Instagram , by Region USD Million (2017-2022)
  • Table 11. Pharma and Healthcare Social Media Others , by Region USD Million (2017-2022)
  • Table 12. South America Pharma and Healthcare Social Media, by Country USD Million (2017-2022)
  • Table 13. South America Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 14. South America Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 15. Brazil Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 16. Brazil Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 17. Argentina Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 18. Argentina Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 19. Rest of South America Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 20. Rest of South America Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 21. Asia Pacific Pharma and Healthcare Social Media, by Country USD Million (2017-2022)
  • Table 22. Asia Pacific Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 23. Asia Pacific Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 24. China Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 25. China Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 26. Japan Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 27. Japan Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 28. India Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 29. India Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 30. South Korea Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 31. South Korea Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 32. Taiwan Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 33. Taiwan Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 34. Australia Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 35. Australia Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 36. Rest of Asia-Pacific Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 37. Rest of Asia-Pacific Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 38. Europe Pharma and Healthcare Social Media, by Country USD Million (2017-2022)
  • Table 39. Europe Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 40. Europe Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 41. Germany Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 42. Germany Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 43. France Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 44. France Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 45. Italy Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 46. Italy Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 47. United Kingdom Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 48. United Kingdom Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 49. Netherlands Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 50. Netherlands Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 51. Rest of Europe Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 52. Rest of Europe Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 53. MEA Pharma and Healthcare Social Media, by Country USD Million (2017-2022)
  • Table 54. MEA Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 55. MEA Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 56. Middle East Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 57. Middle East Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 58. Africa Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 59. Africa Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 60. North America Pharma and Healthcare Social Media, by Country USD Million (2017-2022)
  • Table 61. North America Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 62. North America Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 63. United States Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 64. United States Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 65. Canada Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 66. Canada Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 67. Mexico Pharma and Healthcare Social Media, by Application USD Million (2017-2022)
  • Table 68. Mexico Pharma and Healthcare Social Media, by Social Media USD Million (2017-2022)
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Pharma and Healthcare Social Media: by Application(USD Million)
  • Table 79. Pharma and Healthcare Social Media Hospitals , by Region USD Million (2023-2028)
  • Table 80. Pharma and Healthcare Social Media Clinics , by Region USD Million (2023-2028)
  • Table 81. Pharma and Healthcare Social Media Pharmaceutical , by Region USD Million (2023-2028)
  • Table 82. Pharma and Healthcare Social Media Others , by Region USD Million (2023-2028)
  • Table 83. Pharma and Healthcare Social Media: by Social Media(USD Million)
  • Table 84. Pharma and Healthcare Social Media Facebook , by Region USD Million (2023-2028)
  • Table 85. Pharma and Healthcare Social Media LinkedIn , by Region USD Million (2023-2028)
  • Table 86. Pharma and Healthcare Social Media Youtube , by Region USD Million (2023-2028)
  • Table 87. Pharma and Healthcare Social Media Instagram , by Region USD Million (2023-2028)
  • Table 88. Pharma and Healthcare Social Media Others , by Region USD Million (2023-2028)
  • Table 89. South America Pharma and Healthcare Social Media, by Country USD Million (2023-2028)
  • Table 90. South America Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 91. South America Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 92. Brazil Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 93. Brazil Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 94. Argentina Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 95. Argentina Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 96. Rest of South America Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 97. Rest of South America Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 98. Asia Pacific Pharma and Healthcare Social Media, by Country USD Million (2023-2028)
  • Table 99. Asia Pacific Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 100. Asia Pacific Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 101. China Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 102. China Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 103. Japan Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 104. Japan Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 105. India Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 106. India Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 107. South Korea Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 108. South Korea Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 109. Taiwan Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 110. Taiwan Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 111. Australia Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 112. Australia Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 113. Rest of Asia-Pacific Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 114. Rest of Asia-Pacific Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 115. Europe Pharma and Healthcare Social Media, by Country USD Million (2023-2028)
  • Table 116. Europe Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 117. Europe Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 118. Germany Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 119. Germany Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 120. France Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 121. France Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 122. Italy Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 123. Italy Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 124. United Kingdom Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 125. United Kingdom Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 126. Netherlands Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 127. Netherlands Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 128. Rest of Europe Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 129. Rest of Europe Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 130. MEA Pharma and Healthcare Social Media, by Country USD Million (2023-2028)
  • Table 131. MEA Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 132. MEA Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 133. Middle East Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 134. Middle East Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 135. Africa Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 136. Africa Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 137. North America Pharma and Healthcare Social Media, by Country USD Million (2023-2028)
  • Table 138. North America Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 139. North America Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 140. United States Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 141. United States Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 142. Canada Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 143. Canada Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 144. Mexico Pharma and Healthcare Social Media, by Application USD Million (2023-2028)
  • Table 145. Mexico Pharma and Healthcare Social Media, by Social Media USD Million (2023-2028)
  • Table 146. Research Programs/Design for This Report
  • Table 147. Key Data Information from Secondary Sources
  • Table 148. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharma and Healthcare Social Media: by Application USD Million (2017-2022)
  • Figure 5. Global Pharma and Healthcare Social Media: by Social Media USD Million (2017-2022)
  • Figure 6. South America Pharma and Healthcare Social Media Share (%), by Country
  • Figure 7. Asia Pacific Pharma and Healthcare Social Media Share (%), by Country
  • Figure 8. Europe Pharma and Healthcare Social Media Share (%), by Country
  • Figure 9. MEA Pharma and Healthcare Social Media Share (%), by Country
  • Figure 10. North America Pharma and Healthcare Social Media Share (%), by Country
  • Figure 11. Global Pharma and Healthcare Social Media share by Players 2022 (%)
  • Figure 12. Global Pharma and Healthcare Social Media share by Players (Top 3) 2022(%)
  • Figure 13. Global Pharma and Healthcare Social Media share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. AstraZeneca plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 16. AstraZeneca plc (United Kingdom) Revenue: by Geography 2022
  • Figure 17. Sermo (United States) Revenue, Net Income and Gross profit
  • Figure 18. Sermo (United States) Revenue: by Geography 2022
  • Figure 19. Doximity (United States) Revenue, Net Income and Gross profit
  • Figure 20. Doximity (United States) Revenue: by Geography 2022
  • Figure 21. Abbott Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 22. Abbott Healthcare (United States) Revenue: by Geography 2022
  • Figure 23. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Merck KGaA (Germany) Revenue: by Geography 2022
  • Figure 25. Unmetric (United States) Revenue, Net Income and Gross profit
  • Figure 26. Unmetric (United States) Revenue: by Geography 2022
  • Figure 27. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Pfizer Inc. (United States) Revenue: by Geography 2022
  • Figure 29. AbbVie Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. AbbVie Inc. (United States) Revenue: by Geography 2022
  • Figure 31. GlaxoSmithKline plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. GlaxoSmithKline plc. (United Kingdom) Revenue: by Geography 2022
  • Figure 33. Global Pharma and Healthcare Social Media: by Application USD Million (2023-2028)
  • Figure 34. Global Pharma and Healthcare Social Media: by Social Media USD Million (2023-2028)
  • Figure 35. South America Pharma and Healthcare Social Media Share (%), by Country
  • Figure 36. Asia Pacific Pharma and Healthcare Social Media Share (%), by Country
  • Figure 37. Europe Pharma and Healthcare Social Media Share (%), by Country
  • Figure 38. MEA Pharma and Healthcare Social Media Share (%), by Country
  • Figure 39. North America Pharma and Healthcare Social Media Share (%), by Country
List of companies from research coverage that are profiled in the study
  • AstraZeneca plc (United Kingdom)
  • Sermo (United States)
  • Doximity (United States)
  • Abbott Healthcare (United States)
  • Merck KGaA (Germany)
  • unmetric (United States)
  • Pfizer Inc. (United States)
  • AbbVie Inc. (United States)
  • GlaxoSmithKline plc. (United Kingdom)
Select User Access Type

Key Highlights of Report


Apr 2023 236 Pages 58 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Pharma and Healthcare Social Media Market are AstraZeneca plc (United Kingdom), Sermo (United States), Doximity (United States), Abbott Healthcare (United States), Merck KGaA (Germany), unmetric (United States), Pfizer Inc. (United States), AbbVie Inc. (United States) and GlaxoSmithKline plc. (United Kingdom) etc.
Hospitals segment in Global market to hold robust market share owing to "Growing Demand for Online Presence of Companies for Brand Awareness and Global Reach ".

Know More About Global Pharma and Healthcare Social Media Report?